Evidence for the existence of pyrimidinergic transmission in rat brain
dc.contributor.author | Ulus, İsmail H. | |
dc.contributor.author | Wurtman, Richard J. | |
dc.contributor.buuauthor | Cansev, Mehmet | |
dc.contributor.buuauthor | Orhan, Fulya | |
dc.contributor.buuauthor | Yaylagül, Esra O. | |
dc.contributor.buuauthor | Işık, Esra | |
dc.contributor.buuauthor | Türkyılmaz, Mesut | |
dc.contributor.buuauthor | Aydın, Sami | |
dc.contributor.buuauthor | Gümüş, Abdullah | |
dc.contributor.buuauthor | Sevinç, Cansu | |
dc.contributor.buuauthor | Coşkun, Necdet | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Farmakoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Fen Edebiyat Fakültesi/Biyoloji Bölümü. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Fen Edebiyat Fakültesi/Kimya Bölümü. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi. | tr_TR |
dc.contributor.orcid | 0000-0002-5206-1185 | |
dc.contributor.orcid | 0000-0002-4101-8448 | |
dc.contributor.researcherid | M-9071-2019 | |
dc.contributor.researcherid | FRQ-5179-2022 | |
dc.contributor.researcherid | GWJ-0755-2022 | |
dc.contributor.researcherid | EBA-0754-2022 | |
dc.contributor.researcherid | HUU-9736-2023 | |
dc.contributor.researcherid | AAL-1786-2020 | |
dc.contributor.researcherid | B-1200-2012 | |
dc.contributor.researcherid | ABH-4915-2020 | |
dc.contributor.researcherid | CCT-7508-2022 | |
dc.contributor.scopusid | 8872816100 | tr_TR |
dc.contributor.scopusid | 55866311800 | tr_TR |
dc.contributor.scopusid | 55618956600 | tr_TR |
dc.contributor.scopusid | 50761143600 | tr_TR |
dc.contributor.scopusid | 56320252500 | tr_TR |
dc.contributor.scopusid | 7005387015 | tr_TR |
dc.contributor.scopusid | 56473463900 | tr_TR |
dc.contributor.scopusid | 56473593500 | tr_TR |
dc.contributor.scopusid | 7004177880 | tr_TR |
dc.date.accessioned | 2024-03-19T08:01:10Z | |
dc.date.available | 2024-03-19T08:01:10Z | |
dc.date.issued | 2015-04 | |
dc.description.abstract | The uridine nucleotides uridine-5'-triphosphate (UTP) and uridine-5'-diphosphate (UDP) have previously been identified in media from cultured cells. However, no study to date has demonstrated their presence in brain extracellular fluid (ECF) obtained in vivo. Using a novel method, we now show that UTP and UDP, as well as uridine, are detectable in dialysates of striatal ECF obtained from freely-moving rats. Intraperitoneal (i.p.) administration of uridine or exposure of striatum to depolarizing concentrations of potassium chloride increases extracellular uridine, UTP and UDP, while tetrodotoxin (TTX) decreases their ECF levels. Uridine administration also enhances cholinergic neurotransmission which is accompanied by enhanced brain levels of diacylglycerol (DAG) and inositol trisphosphate (IP3) and blocked by suramin, but not by PPADS (pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid) or MRS2578 suggesting a possible mediation of P2Y2 receptors activated by UTP. These observations suggest that uridine, UTP and UDP may function as pyrimidinergic neurotransmitters, and that enhancement of such neurotransmission underlies pharmacologic effects of exogenous uridine on the brain. | en_US |
dc.description.sponsorship | Türkiye Bilimler Akademisi | tr_TR |
dc.identifier.citation | Cansev, M. vd. (2015). "Evidence for the existence of pyrimidinergic transmission in rat brain". Neuropharmacology, 91, 77-86. | en_US |
dc.identifier.doi | https://doi.org/10.1016/j.neuropharm.2014.12.019 | |
dc.identifier.endpage | 86 | tr_TR |
dc.identifier.issn | 0028-3908 | |
dc.identifier.issn | 1873-7064 | |
dc.identifier.pubmed | 25541414 | tr_TR |
dc.identifier.scopus | 2-s2.0-84920747605 | tr_TR |
dc.identifier.startpage | 77 | tr_TR |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0028390814004705 | |
dc.identifier.uri | https://hdl.handle.net/11452/40482 | |
dc.identifier.volume | 91 | tr_TR |
dc.identifier.wos | 000350926100009 | |
dc.indexed.pubmed | PubMed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Pergamon-Elsevier Science | en_US |
dc.relation.collaboration | Yurt dışı | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.relation.journal | Neuropharmacology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.relation.tubitak | 108S354 | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Neurosciences & neurology | en_US |
dc.subject | Pharmacology & pharmacy | en_US |
dc.subject | Uridine | en_US |
dc.subject | UTP | en_US |
dc.subject | UDP | en_US |
dc.subject | Pyrimidinergic | en_US |
dc.subject | Neurotransmission | en_US |
dc.subject | P2Y receptors | en_US |
dc.subject | Uridine nucleotide receptor | en_US |
dc.subject | CDP-choline levels | en_US |
dc.subject | P2Y receptors | en_US |
dc.subject | Docosahexaenoic acid | en_US |
dc.subject | Alzheimers-disease | en_US |
dc.subject | Functional expression | en_US |
dc.subject | Phospholipase-C | en_US |
dc.subject | Nervous-system | en_US |
dc.subject | Ecto-atpase | en_US |
dc.subject | Cells | en_US |
dc.subject | Acetylcholine | en_US |
dc.subject | Animals | en_US |
dc.subject | Brain chemistry | en_US |
dc.subject | Choline | en_US |
dc.subject | Corpus striatum | en_US |
dc.subject | Extracellular fluid | en_US |
dc.subject | Male | en_US |
dc.subject | Rats | en_US |
dc.subject | Rats, Sprague-Dawley | en_US |
dc.subject | Receptors, purinergic P2Y | en_US |
dc.subject | Uridine | en_US |
dc.subject | Uridine diphosphate | en_US |
dc.subject | Uridine triphosphate | en_US |
dc.subject.emtree | Diacylglycerol | en_US |
dc.subject.emtree | Inositol trisphosphate | en_US |
dc.subject.emtree | Mrs 2578 | en_US |
dc.subject.emtree | Purinergic P2Y receptor antagonist | en_US |
dc.subject.emtree | Purinergic P2Y2 receptor | en_US |
dc.subject.emtree | Purinergic P2Y6 receptor | en_US |
dc.subject.emtree | Pyridoxal phosphate 6 azophenyl 2',4' disulfonic acid | en_US |
dc.subject.emtree | Suramin | en_US |
dc.subject.emtree | Unclassified drug | en_US |
dc.subject.emtree | Uridine | en_US |
dc.subject.emtree | Uridine diphosphate | en_US |
dc.subject.emtree | Uridine triphosphate | en_US |
dc.subject.emtree | Acetylcholine | en_US |
dc.subject.emtree | Choline | en_US |
dc.subject.emtree | Purinergic P2Y receptor | en_US |
dc.subject.emtree | Uridine | en_US |
dc.subject.emtree | Uridine diphosphate | en_US |
dc.subject.emtree | Uridine triphosphate | en_US |
dc.subject.emtree | Analysis of variance | en_US |
dc.subject.emtree | Animal experiment | en_US |
dc.subject.emtree | Animal tissue | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Brain level | en_US |
dc.subject.emtree | Cerebrospinal fluid | en_US |
dc.subject.emtree | Cholinergic transmission | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Corpus striatum | en_US |
dc.subject.emtree | Enzyme analysis | en_US |
dc.subject.emtree | Extracellular fluid | en_US |
dc.subject.emtree | High performance liquid chromatography | en_US |
dc.subject.emtree | Hydrolysis | en_US |
dc.subject.emtree | In vivo study | en_US |
dc.subject.emtree | Limit of detection | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Membrane depolarization | en_US |
dc.subject.emtree | Microdialysis | en_US |
dc.subject.emtree | Neurotransmission | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.emtree | Pyrimidinergic transmission | en_US |
dc.subject.emtree | Rat | en_US |
dc.subject.emtree | Tandem mass spectrometry | en_US |
dc.subject.emtree | Animal | en_US |
dc.subject.emtree | Brain chemistry | en_US |
dc.subject.emtree | Chemistry | en_US |
dc.subject.emtree | Drug effects | en_US |
dc.subject.emtree | Extracellular fluid | en_US |
dc.subject.emtree | Metabolism | en_US |
dc.subject.emtree | Sprague Dawley rat | en_US |
dc.subject.mesh | Acetylcholine | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Brain chemistry | en_US |
dc.subject.mesh | Choline | en_US |
dc.subject.mesh | Corpus striatum | en_US |
dc.subject.mesh | Extracellular fluid | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Rats | en_US |
dc.subject.mesh | Rats, Sprague-Dawley | en_US |
dc.subject.mesh | Receptors, purinergic P2Y | en_US |
dc.subject.mesh | Uridine | en_US |
dc.subject.mesh | Uridine diphosphate | en_US |
dc.subject.mesh | Uridine triphosphate | en_US |
dc.subject.scopus | Purinergic P2Y2 receptors; Uridine adenosine tetraphosphate; Animals | en_US |
dc.subject.wos | Neurosciences | en_US |
dc.subject.wos | Pharmacology & pharmacy | en_US |
dc.title | Evidence for the existence of pyrimidinergic transmission in rat brain | en_US |
dc.type | Article | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: